We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Regulators must use this process guidance note (PGN) to assess applications and write permits for the formulation and finishing of pharmaceutical products
Criteria applied by the VMD for accepting and agreeing the invented name of veterinary medicinal products.
This study explores the structural properties of the ERG22+ formulation tool (Her Majesty’s Prison and Probation Service, 2011) which is used in the management of extremist offenders by the criminal justice system of England and Wales.
Advice for manufacturers of Class I medical devices for placing products on the UK market
Information on comparator products used in studies supporting abridged marketing authorisation application.
Decision on application for authorisation (review report) under UK REACH.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).